medigraphic.com
ISSN 2007-6509 (Print)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.

2026, Number S1

<< Back Next >>

Rev Mex Med Transfus 2026; 18 (S1)

Reasons for deferral and exclusion according to blood donor selection process categories

Chi-Kú JD, Cabrera-Maldonado LM

Language: Spanish
References: 14
Page: 25-31
PDF size: 797.79 Kb.


ABSTRACT

Introduction: the blood donor selection process ensures transfusion safety but reduces the number of eligible donors. Objective: to analyze the reasons for donor deferral and exclusion using categories derived from the blood donor selection process. Material and methods: an observational, descriptive, retrospective, cross-sectional study was conducted. Records from 989 blood donation candidates attended during 2021 at the Blood Collection Center of the General Hospital of Cozumel were analyzed. Reasons for deferral or exclusion were classified into the following categories: Donation history, Donation requirements, Veins, Laboratory, Medical history, and Physical examination. Results: a total of 605 (61.2%) candidates were deferred or excluded, and 609 reasons for deferral or exclusion were identified. The Requirements category was the most frequent (45.8%), followed by Laboratory (33.3%). The most frequent unmet requirements were sleeping less than six hours, insufficient time availability, inadequate fasting, and medication use within the deferral period. Conclusions: most deferrals were associated with unmet donation requirements that can be modified before donation. Strengthening candidate education and information could reduce avoidable deferrals, increase donor recruitment, and contribute to transfusion safety.


REFERENCES

  1. World Health Organization. Blood safety and availability [Internet].Geneva: World Health Organization; 2026. Available in: https://www.who.int/es/news-room/fact-sheets/detail/blood-safety-andavailability

  2. Centro Nacional de la Transfusión Sanguínea. Suministro desangre y componentes sanguíneos para transfusiones en losestados de la República Mexicana en el año 2025. Ciudad deMéxico: Secretaría de Salud; 2026.

  3. Secretaría de Salud. Norma Oficial Mexicana NOM-253-SSA1-2012, para la disposición de sangre humana y suscomponentes con fines terapéuticos [Internet]. Ciudad deMéxico: Secretaría de Salud; 2012. Última reforma publicada el22 de septiembre de 2015.

  4. Kasraian L, Sadeghi E, Khakrah Z, Farahangiz M, Naderi N. Blooddonor deferral patterns in Iran: six-year national analysis (2016-2021). Blood Transfus.. doi: 10.2450/BloodTransfus.1206.

  5. Zhang Y, Wei S, Li X, Zhang S, Liu Y, Li T et al. Pre-donation deferralrates and causes among whole blood and apheresis plateletdonors in China: A multi-centre retrospective study (2016-2024).Vox Sang. 2026; 121 (7): 927-935. doi: 10.1111/vox.70246.

  6. Centro Nacional de la Transfusión Sanguínea. Guía nacionalde criterios para la selección de donantes de sangre y suscomponentes sanguíneos para el uso terapéutico (Versión 2).Ciudad de México: Secretaría de Salud; 2022.

  7. V S, R A, Haran A H, I SK, James S. Analysis of blood donor deferralpattern at a tertiary care hospital in Chennai: a cross-sectionalretrospective study. Cureus. 2024; 16 (8): e67541. doi: 10.7759/cureus.67541.

  8. Singh AK, Bharati JK, Shivhare A, Mohan Y, Singh N. Analysis of blooddonor deferral pattern in Uttar Pradesh, India. Bioinformation.2025; 21 (7): 1942-1946. doi: 10.6026/973206300211942.

  9. Díaz-Gaytán JJ, Pérez-Flores G, Torres-Tirado D, Pérez-García LA.Causas de diferimiento en candidatos a donación sanguínea:estudio retrospectivo en un hospital de la Huasteca Potosina.QUIBIOUAS Rev Cienc Quím Biol. 2026; 5: 20-29.

  10. Navarrete-Castro J, de la Fuente-Dorado L, Siria-Torreblanca N,de la Rosa-Romero N, Lebrija-Córdova V, Alvarado-Torres C et al.Análisis multivariado de las 10 principales causas de rechazo endonadores de sangre del CMN 20 de Noviembre, ISSSTE. Rev MexMed Transfus. 2024; 16 (1): 7-15. doi: 10.35366/114940.

  11. Silva PRT, Almeida RE. Doadores inaptos temporariamente:um público potencial para aumento de doações de sangue.Hematol Transfus Cell Ther. 2025; 47 (Suppl 3): 105730. doi: 10.1016/j.htct.2025.105730.

  12. Dias PB, Lissa NM, Skare T, Fávero KB, Almeida PTR, Nisihara R.Pre-donation deferral of blood donors in a Brazilian blood bank:a 10-year experience. Transfus Med. 2019; 29 (6): 448-453.

  13. Organización Panamericana de la Salud. Elegibilidad para ladonación de sangre: recomendaciones para la educación y laselección de donantes potenciales de sangre. Actualización.Washington (DC): OPS; 2025.

  14. Chi-Kú JD, Cabrera-Maldonado LM. Análisis relacional y predictivodel desconocimiento de los requisitos y la aptitud para donarsangre en Cozumel. Rev Mex Med Transfus. 2025; 17 (1): 7-14. doi:10.35366/121307.




2020     |     www.medigraphic.com